Is CG a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Fee-related earnings and the shift toward permanent capital, with total aum at ~$485B as of June 30, 2026, up ~4% year over year. The bear case rests on fundraising is cyclical and reflexive, so a stretch of weak fund performance or a closed exit window can shrink fee-earning AUM at the same moment carried interest stops converting to cash. Analysts covering it are spread from $49.00 to $73.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Fundraising is cyclical and reflexive, so a stretch of weak fund performance or a closed exit window can shrink fee-earning AUM at the same moment carried interest stops converting to cash. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $49.00, +2.5% from the $47.80 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Fee-related earnings and the shift toward permanent capital. Record FRE of ~$358 million in Q2 2026 at a ~47% margin is the metric management has organised the firm around, because it is the part of the P&L that does not require an exit to materialise. The most optimistic analyst target on CG is $73.00, +52.7% from the $47.80 price. That figure is only reachable if this thesis works close to its best case.

Fundraising is cyclical and reflexive, so a stretch of weak fund performance or a closed exit window can shrink fee-earning AUM at the same moment carried interest stops converting to cash. Performance fees are inherently lumpy and unrealised carry is a mark, not money, meaning distributable earnings can fall by half in a quiet quarter without anything fundamental breaking. Higher-for-longer rates raise financing costs across portfolio companies and compress private-market valuations, while heavy competition for direct lending assets pressures credit spreads. On the legal side, a Delaware fiduciary-duty suit brought by a pension fund against co-founders William Conway, Daniel D'Aniello and David Rubenstein and other directors over a ~$344 million payment to terminate the firm's tax receivable agreement was allowed to proceed in 2024 and remains a derivative matter rather than a securities-fraud class action; no active securities-fraud class action against Carlyle was identified as of August 2026. Regulators in the US and Europe continue to scrutinise fee disclosure, valuation practices and the push of illiquid strategies into retail and retirement channels, which is precisely where much of the growth plan sits. The most pessimistic published target is $49.00, +2.5% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Founded in 1987 and public since 2012, Carlyle manages roughly $485 billion across private equity, credit and its AlpInvest secondaries arm.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Fee-related earnings and the shift toward permanent capital) stalling in the reported numbers rather than in the narrative, the risk above (fundraising is cyclical and reflexive, so a stretch of weak fund performance or a closed exit window can shrink fee-earning AUM at the same moment carried interest stops converting to cash) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

CG is The Carlyle Group Inc., an alternative asset manager headquartered in Washington, DC and listed on the Nasdaq Global Select Market since its May 2012 IPO. It is a US operating company with ~2,500 employees and ~$485 billion of assets under management, not a fund or a trust.

Shares trade on the Nasdaq under CG and can be bought through any brokerage that handles US listed equities, including fractional purchases at brokers that support them. Owning CG is different from investing in a Carlyle fund: shareholders own the management company and its share of fees and carry, while the underlying private-equity funds remain restricted to qualified institutional and accredited investors.

GAAP revenue for alternative managers folds in unrealised investment marks and consolidated fund results, so it swings by billions with no change in the operating business. Fee-related earnings strip that out and measure the recurring management-fee stream minus the cost of running the firm, which is why FRE of ~$358 million in Q2 2026 was described as a record while headline revenue fell sharply year over year.